Digital AI, trust, and transformation: What the NHS needs for safe a... As AI becomes more embedded within national health system priorities, the need for clear and responsible guardrails has become increasingly critical.
Digital AI won't replace the MSL. But it is changing what makes the ... The shift that matters is not about replacing the MSL's judgement. It is about removing the friction around it.
Digital 4 Takeaways from Google Cloud’s NEXT 2026 and what’s on the ... When you attend events hosted by industry leaders like Google, you expect to be impressed by how technology continues to evolve.
Digital Pharma’s new gatekeeper: AI’s rising role The AI bouncer guarding the door of healthcare information isn’t going anywhere and isn’t changing its standards.
R&D Reimagining biopharma: How AI is reshaping discovery, develo... No longer confined to experimental pilots, AI is becoming a catalyst for change across the entire biopharma value chain - but there are challenges.
Digital AI is reshaping drug discovery - Now it must prove it can be... As innovation pushes the boundaries of speed and scale, a question remains: can we use transparency as a way to prove safety and build public trust?
News MSD's Sac-TMT delivers in first phase 3 readout MSD's TROP2-targeting antibody-drug conjugate sac-TMT, licensed from China's Kelun, has improved survival in a late-stage endometrial cancer trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.